NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function and slow or halt the progression of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease and motor neurone disease
Location: United Kingdom, England, Stevenage
Employees: 11-50
Total raised: $19.01M
Founded date: 2018
Investors 2
| Date | Name | Website |
| 11.07.2022 | Omega Fund... | omegafunds... |
| 18.11.2022 | Brandon Ca... | brandoncap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.11.2022 | Series A | $18.34M | - |
| 23.08.2021 | Seed | $670.46K | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 09.10.2023 | Brandon Capital Joins AstronauTx’ £48 million ($61 million) ... | Brandon Capital Joins AstronauTx’ £48 million ($61 million) Series A Financing to Create New Treatme... | brandoncap... |
| 22.02.2023 | NRG Therapeutics Awarded Second $500K Grant from The Michael... | - | globenewsw... |
| 09.11.2022 | Brandon Capital Invests in Neuroscience Company NRG Therapeu... | Brandon Capital, Australasia’s leading life science venture capital firm, is pleased to announce its... | brandoncap... |
| 09.11.2022 | NRG Therapeutics Raises £16M in Series A Funding | NRG Therapeutics, a Stevenage, UK-based neuroscience company, raised £16M in Series A funding. The ... | finsmes.co... |
| - | NRG Therapeutics | “Home - NRG Therapeutics” | fastfounde... |